Prescription Drugs - Madagascar

  • Madagascar
  • Madagascar is projected to witness a significant increase in revenue within the Prescription Drugs market, with an estimated value of US$55.17m in 2024.
  • This revenue is expected to exhibit a compound annual growth rate (CAGR) of 2.11% during the period of 2024-2029, resulting in a market volume of US$61.25m by 2029.
  • When compared on a global scale, United States is anticipated to generate the highest revenue within the Prescription Drugs market, reaching a staggering US$358.90bn in 2024.
  • In terms of per person revenues, in Madagascar is expected to generate US$1.78 in 2024, taking into account the total population figures.
  • This indicates the market potential and importance of the Prescription Drugs market within the country.
  • Madagascar has seen a significant increase in the demand for prescription drugs due to the rising prevalence of infectious diseases in the country.

Key regions: Japan, China, Europe, Australia, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Prescription Drugs (Pharmacies) market in Madagascar has been experiencing significant growth in recent years, driven by various factors such as changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Prescription Drugs (Pharmacies) market in Madagascar have been shifting towards a greater emphasis on convenience and accessibility. Customers are increasingly looking for pharmacies that offer a wide range of prescription drugs and over-the-counter medications, as well as additional services such as health consultations and home delivery. This shift in preferences is influenced by global trends where customers are seeking more personalized and convenient healthcare solutions. Trends in the market also play a crucial role in the development of the Prescription Drugs (Pharmacies) market in Madagascar. One notable trend is the increasing demand for generic drugs. Generic drugs are more affordable and offer similar therapeutic benefits as branded drugs. This trend is driven by cost-conscious consumers and the efforts of the government to promote the use of generic drugs to reduce healthcare expenditure. As a result, pharmacies in Madagascar are expanding their offerings of generic drugs to meet the growing demand. Another trend in the market is the integration of technology in pharmacy services. Pharmacies in Madagascar are adopting digital platforms and online ordering systems to improve efficiency and provide a seamless customer experience. This trend is in line with global advancements in healthcare technology, where digital solutions are transforming the way pharmacies operate and interact with customers. Local special circumstances also contribute to the development of the Prescription Drugs (Pharmacies) market in Madagascar. The country has a growing population and an increasing burden of chronic diseases, which drives the demand for prescription drugs. Additionally, the government has been implementing policies to improve access to healthcare services, including the expansion of the healthcare infrastructure and the establishment of community pharmacies in rural areas. These initiatives create opportunities for pharmacies to expand their presence and cater to a wider customer base. Underlying macroeconomic factors, such as economic growth and increasing disposable income, also play a role in the development of the Prescription Drugs (Pharmacies) market in Madagascar. As the economy grows, individuals have more purchasing power to afford prescription drugs and other healthcare services. This drives the demand for pharmacies and contributes to market expansion. In conclusion, the Prescription Drugs (Pharmacies) market in Madagascar is developing due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The shift towards convenience and accessibility, the demand for generic drugs, the integration of technology, the growing population and burden of chronic diseases, and the improving economic conditions all contribute to the growth of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)